A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

NCT02770521 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Treprostinil
DRUG: Placebo
DRUG: LY900014
DRUG: Insulin Lispro

Sponsor

Eli Lilly and Company